by Kelly Zygowski, category analyst, part of Monthly Retailer Category Tips

Update your pain relief department to meet customer needs and build revenue.

  • Your most valuable pain relief shoppers are those that purchasleg paine both internal and external treatment products to ease their pain. Nearly a quarter of households purchase both. Simplify your customers’ shopping experience by following your TEMPS® planogram to stock the most popular and profitable brands in the independent pharmacy channel.
  • Advil is up 4.9% from a year ago. Despite initial negative press around misleading reports about NSAIDS like Advil (ibuprofen) and the potential they could worsen the severity of COVID-19, the brand has rebounded over the last 52 weeks, even showing gains. If you reduced your inventory as a result of the controversy, return to normal stocking levels of this important brand along with comparable private label products.
  • Forty-three percent of the new items launched recently were in the external pain relief subcategory. Twenty-eight percent of these items listed menthol as the active ingredient, while 18% listed diclofenac sodium. These ingredients target muscle pain and arthritis, respectively. Educate your customers about the different ingredients in external pain relief products so they can choose the item that addresses the type of pain they are trying to relieve.

Source: HRG Tri-PAC™ data, 52 weeks